APOBEC3G inhibits elongation of HIV-1 reverse transcripts. - Test2 - elhamkhani - TriplyDB

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

http://www.wikidata.org/entity/Q33389841

about

HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors The range of human APOBEC3H sensitivity to lentiviral Vif proteins A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Host restriction factors for hepatitis C virus Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes.Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells Where in the Cell Are You? Probing HIV-1 Host Interactions through Advanced Imaging Techniques RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1 Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy Intrinsic antiviral immunity Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.Macaques as model hosts for studies of HIV-1 infection Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.Novel approaches to inhibiting HIV-1 replication.Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.CCR6 ligands inhibit HIV by inducing APOBEC3G.Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells.The macrophage in HIV-1 infection: from activation to deactivation?Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.Host hindrance to HIV-1 replication in monocytes and macrophages.HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

P2860

Q24297395-004C99B8-2D7E-4254-833C-E612B6DC1EAC Q24310511-BC3436F5-2FE2-452B-AADB-3A3242D0288C Q24596322-5F3FD854-3960-4207-A827-FCC5B51FF6F5 Q24615552-14544718-9A29-47BC-BC15-4C9BC34228E8 Q24618320-D06E1223-5EC4-4549-A83E-75CA57785CE7 Q24619114-3BA9C455-89E9-42C4-A708-78F7AB0101F5 Q24653931-63D55138-34A6-419D-8D91-C2A5EF626125 Q24656551-200B555F-6684-4271-B3A7-18E41F096444 Q26773258-9BE8548B-FD3D-4F30-937F-E8B9C9EEBDC7 Q26774878-DE6CFFA8-34E4-4781-BBBE-CE2C9BE6A2D3 Q26823568-417F19C8-99B4-4B6A-8389-62D0AAA05F61 Q26862780-4019CFFF-A746-4FC5-B78D-DDA37C089DBF Q27022978-D2A38384-E3EE-4DFF-A703-C842FD680C79 Q27025150-5C71A479-C642-444A-B643-9AB4FBF9CB15 Q27316160-1255742C-6B76-4CF0-A687-CB8B8A1C684D Q28068375-603B8C57-B184-4166-AE15-3E7074C1F159 Q28077744-09AE26E3-1EFC-444A-A573-E9F18456109B Q28474904-03C5CA18-46E4-4557-959E-7EBDE53A1D14 Q28480578-BF36F2E5-0CCC-4FD5-B8C8-DFCDD2ADC349 Q28709929-87534DBB-2BA5-4005-ABAA-72A1CD18018B Q30381745-0568C079-8C07-4008-A122-14170525DBB0 Q30653348-63E8D6BA-EFF1-46FD-94F6-B9351BEA4AC8 Q31036522-1EE6C0B2-E005-4356-A969-06D929FBF2AA Q33602923-BDBD83DD-EBA3-491E-B2FB-F99290745140 Q33624690-7B4EC5D5-A0E9-43E3-B482-8A4ABF3F0743 Q33634092-BCEDABC5-D2C4-4FCD-9D77-D7826BBC9CB5 Q33650603-DDB07C89-DA3B-403D-A91B-A5BB6C628EEA Q33654949-D18B0D3D-F990-4D82-A686-F39DD91FFFA6 Q33697355-9774A475-A712-4FAB-911D-D8299C86457A Q33753961-4E14DF99-B52F-4F87-BFD5-54BB50899611 Q33810779-AA14A4A7-C08D-4D94-9DE6-E7607BC5DA5F Q33815187-1A23EBA1-3DF4-4195-80BB-512FCB41AAC9 Q33826968-8EFE6176-66F2-4BCF-99DB-59357F60CBF9 Q33846376-EC971BD6-6DD6-4482-B7B3-37DE4D8F56CF Q33865132-D79A4157-3319-43FD-B811-F28D17E74DC1 Q33877299-83CEB19E-FED3-4E89-A632-7C3333D69236 Q34037651-124B18EF-E452-446D-A0CA-29507F6B1C4F Q34052968-99DB3B23-6240-4413-A750-2F25329C2065 Q34107265-522C3517-496D-488A-A9E4-79C907320E42 Q34120302-D505F230-6F4E-45CE-8977-51A998485381

P2860

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

http://www.wikidata.org/entity/Q33389841

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@ast

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@en

type

label

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@ast

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@en

prefLabel

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@ast

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@en

P1433

Q33389841-DD2152A9-0612-4E4A-9E8D-BFA93B011CC4

P1476

Q33389841-29474EBE-6513-49D8-B0CB-E0D4B3C6A8F0

P2093

Q33389841-5ABBF9CF-3B0D-4FBE-B1AB-723AAAC4F79A

Q33389841-B17EDC0E-0CC2-4200-A6D1-A7E9B827D53D

Q33389841-F6ADA918-74BE-4F56-A564-AA5DEAC4F3A2

P2860

Q33389841-000AE9F2-4DA7-48B9-B4B0-10DE32213B29

Q33389841-0508ECF1-AE8B-42A0-BD93-0240BF61225F

Q33389841-0C8F4E1F-6AA5-48B8-93E4-6D7124D6D3B6

Q33389841-0D236654-6573-45C6-BE74-9429E287CFC2

Q33389841-184D027B-5D73-4CAF-9152-9BFCF3A59F92

Q33389841-1F6DBC1C-0B24-41E5-BFB9-07FAF2A5C59F

Q33389841-2C42A947-2DF1-4F95-89E6-64F49FC1B607

Q33389841-3148BCF4-B825-44F0-9660-F1D3C55A598C

Q33389841-32F1FD00-8E58-4AFE-9192-1E385675AC9B

Q33389841-393F8A59-E22F-4445-A0B2-FD38E174390F

P304

Q33389841-172D6B8A-C81C-498B-A52C-F61DD8BDE978

P31

Q33389841-D93D2CFD-B91F-433D-86E6-79BF44455105

P356

Q33389841-E01E4DCD-7998-4513-AF45-9D7EDFC3ADD1

P433

Q33389841-CCB3D5C0-73E6-4728-B7D6-0AAC341B4FA4

P478

Q33389841-4D63F4FC-25E0-4D07-8860-3553FC43218F

P50

Q33389841-07BE07A1-5BBD-4A4C-B536-C9AD69071435

Q33389841-41AC3C6A-853B-4463-B89F-DB1F339F4080

P577

Q33389841-7BBB345A-3FEA-4F67-A441-728A27DE292F

P5875

Q33389841-09DA63C1-1C74-4F30-8ACC-354EC23988B3

P698

Q33389841-2F326CC8-A352-42A8-AFA2-04BF311AB3A8

P932

Q33389841-76600AB4-C9F9-4829-9A19-3E9FE5B3FB46

P356

JOURNAL.PPAT.1000231

P1433

P1476

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

@en

P2093

Eun-Young Kim

http://www.w3.org/2001/XMLSchema#string

Kate N Bishop

http://www.w3.org/2001/XMLSchema#string

Mohit Verma

http://www.w3.org/2001/XMLSchema#string

P2860

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G

Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1

Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication

7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G

Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

DNA deamination mediates innate immunity to retroviral infection

P304

e1000231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000231

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Michael Henry Malim

Steven M. Wolinsky

P577

2008-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23572573

http://www.w3.org/2001/XMLSchema#string

P698

19057663

http://www.w3.org/2001/XMLSchema#string

P932

2584787

http://www.w3.org/2001/XMLSchema#string